(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ONLY ONO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ONLY ONO

ST13

US500000079369434

Class

5, 44

Filing

79369434

Registration

7464561

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

04/03/2026

Classification

Registered

Trademark type

Word

Nice classes

5, 44

Filing date

01/19/2023

Registration date

08/06/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/06/2024

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

JP

Examiner

CANTONE, KERI H

Law office

L40

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

ONO PHARMACEUTICAL CO., LTD.

Representatives

Perla M. Kuhn Fox Rothschild LLP

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-cancer preparations; chemical preparations for sanitary purposes; chemical preparations for medicinal purposes for treating cardiovascular disordersgenitourinary disordersgynecological diseases and obstetric diseasescancer and its metastasiseye disordersneurologic disorderspsychiatric disordersendocrine and metabolic disordersallergic disordersgastrointestinal disordersimmune diseases and autoimmune diseasesrespiratory diseasesmusculoskeletal and connective tissue disordersinfectious diseasesdermatologic disordershematological disorderinflammatory diseasesearnosedental and throat disordershepatic and biliary disordersAlzheimer's diseasediabetes and its complications; diagnostic preparations for medical purposes; medicated toiletry preparations; sanitary preparations for medical purposes; fungicides; sterilizing preparations; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment and prevention of cardiovascular disordersgenitourinary disordersgynecological diseases and obstetric diseasescancer and its metastasiseye disordersneurologic disorderspsychiatric disordersendocrine and metabolic disordersallergic disordersgastrointestinal disordersimmune diseases and autoimmune diseasesrespiratory diseasesmusculoskeletal and connective tissue disordersinfectious diseasesdermatologic disordershematological disorderinflammatory diseasesearnosedental and throat disordershepatic and biliary disordersAlzheimer's diseasediabetes and its complications; pharmaceutical preparations for cancer supportive care; general and topical anestheticsedative and analgesic drugs; vaccines

Class 44

Provision of medical and medical pharmaceutical information via the Internet; provision of medical information relating to medical benefitsside effectsinteractions of pharmaceuticals and medications; provision of medical information about pharmaceutical products; medicalmedicinal and pharmaceutical consultancy; advisory services relating to pharmaceutical products; provision of information on pharmaceuticals and medical services through computer databases; medical testing for the collection of medical informationanalysis and provision of medical information for diagnostic or treatment purposes; medical testing; medical consultancy and diagnosis via the Internet; online medical counseling services; remote monitoring of patient health status for medical conditions; remote monitoring of medical data for medical diagnosis and treatment; analysis and provision of clinical data of patients for medical diagnostic or treatment purposes; provision of medical information; physical examination; providing medical information about pharmaceuticalsmedical services or health; consultancy services relating to medical servicespharmaceuticalshealth or dispensing of medications; consultancyadvisory and provision of information relating to health care; managed health care services; provision of records of personal health information data such as weightbody fatbody temperaturenumber of stepssleeping hours and blood pressure; nursing care; rental of medical apparatus and instruments

Publications

History of USPTO decisions and trademark events.

27 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/15/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/30/2025

FIMP

FINAL DISPOSITION PROCESSED

01/30/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/06/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/06/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

08/06/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/21/2024

PUBO

PUBLISHED FOR OPPOSITION

05/21/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/01/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/15/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

04/15/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/15/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

04/15/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/15/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/10/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/10/2024

RFNT

REFUSAL PROCESSED BY IB

11/22/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/30/2023

RFRR

REFUSAL PROCESSED BY MPU

10/30/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/27/2023

CNRT

NON-FINAL ACTION WRITTEN

10/26/2023

DOCK

ASSIGNED TO EXAMINER

10/17/2023

MAFR

APPLICATION FILING RECEIPT MAILED

05/23/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/19/2023

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

05/17/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/11/2023

Continuous trademark protection

Get notified about every new filing that threatens ONLY ONO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.